Form 4 for GDRX GoodRx Holdings, Inc.

Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-21 · accession 0001809519-26-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-01-21	2026-01-21	GDRX	Wagner Scott	Dir	M - OptEx	—	+31.4K	216.7K	+17%	—
D	2026-01-21	2026-01-21	GDRX	Wagner Scott	Dir	M - OptEx	$0.00	-31.4K	62.8K	-33%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2026-01-21	M	A	31,394	—	216,663	D	—	—	(F1) The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). (F2) Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2	Derivative	Deferred Stock Unit	2026-01-21	M	D	31,394	$0.00	62,788	D	— · — to —	31,394 Class A Common Stock	(F2) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F1) The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).